4.1
65
Regulatory Development Strategy
Define global regulatory pathway, authority interactions, risks, and submission strategy.
View toolkitStage 4
Regulatory strategy and IND/CTA/global trial readiness
Tools for defining regulatory pathways, preparing clinical trial applications and controlling authority commitments.
What this stage covers
Global regulatory strategy, US IND, EU CTIS, UK CTA, investigator brochures, correspondence, commitments, and eCTD readiness.
How it helps your team: Turn regulatory strategy into owned actions, traceable evidence, and controlled submissions.
8 toolkits
Choose the operational area you need
4.2
97
US IND Preparation & Lifecycle Management
Build and maintain the US IND package and lifecycle.
View toolkit4.3
67
EU CTA / CTIS Preparation & Lifecycle Management
Build and maintain EU CTA/CTIS submission and lifecycle documentation.
View toolkit4.4
54
UK / MHRA Clinical Trial Application Add-On
Add UK-specific clinical trial submission and lifecycle controls.
View toolkit4.5
65
Investigator’s Brochure Development & Maintenance
Build, review, update, and distribute the IB across development.
View toolkit4.6
65
Regulatory Correspondence & Commitments Management
Control health authority correspondence, commitments, responses, and deadlines.
View toolkit4.7
65
eCTD / Publishing Readiness
Prepare submissions for eCTD publishing, QC, module ownership, and defect control.
View toolkit4.8
65
Clinical Trial Registration & Transparency
Manage trial registration, public disclosure, results posting, and transparency controls.
View toolkitNot sure which toolkit fits the work?
Return to the full catalogue and search by process, study, submission or control.